Literature DB >> 21441971

Aqueous extract of lavender (Lavandula angustifolia) improves the spatial performance of a rat model of Alzheimer's disease.

Masoud Soheili Kashani1, Mostafa Rezaei Tavirani, Sayyed Alireza Talaei, Mahmoud Salami.   

Abstract

OBJECTIVE: Alzheimer's disease (AD) is one of the most important neurodegenerative disorders. It is characterized by dementia including deficits in learning and memory. The present study aimed to evaluate the effects of aqueous extract of lavender (Lavandula angustifolia) on spatial performance of AD rats.
METHODS: Male Wistar rats were first divided into control and AD groups. Rat model of AD was established by intracerebroventricular injection of 10 μg Aβ1-42 20 d prior to administration of the lavender extract. Rats in both groups were then introduced to 2 stages of task learning (with an interval of 20 d) in Morris water maze, each followed by one probe test. After the first stage of spatial learning, control and AD animals received different doses (50, 100 and 200 mg/kg) of the lavender extract.
RESULTS: In the first stage of experiment, the latency to locate the hidden platform in AD group was significantly higher than that in control group. However, in the second stage of experiment, control and AD rats that received distilled water (vehicle) showed similar performance, indicating that the maze navigation itself could improve the spatial learning of AD animals. Besides, in the second stage of experiment, control and AD rats that received lavender extract administration at different doses (50, 100, and 200 mg/ kg) spent less time locating the platform (except for the AD rats with 50 mg/kg extract treatment), as compared with their counterparts with vehicle treatment, respectively. In addition, lavender extract significantly improved the performance of control and AD rats in the probe test, only at the dose of 200 mg/kg, as compared with their counterparts with vehicle treatment.
CONCLUSION: The lavender extract can effectively reverse spatial learning deficits in AD rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441971      PMCID: PMC5560344          DOI: 10.1007/s12264-011-1149-7

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  27 in total

1.  Molecular and cellular mediators of Alzheimer's disease inflammation.

Authors:  Ron Strohmeyer; Joseph Rogers
Journal:  J Alzheimers Dis       Date:  2001-02       Impact factor: 4.472

2.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

Authors:  K S Kosik; C L Joachim; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members.

Authors:  R P Friedland; T Fritsch; K A Smyth; E Koss; A J Lerner; C H Chen; G J Petot; S M Debanne
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

4.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

5.  Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project.

Authors:  L Letenneur; V Gilleron; D Commenges; C Helmer; J M Orgogozo; J F Dartigues
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

Review 6.  The role of inflammation in Alzheimer's disease.

Authors:  Ehab E Tuppo; Hugo R Arias
Journal:  Int J Biochem Cell Biol       Date:  2005-02       Impact factor: 5.085

7.  Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial.

Authors:  Shahin Akhondzadeh; Ladan Kashani; Akbar Fotouhi; Soghra Jarvandi; Mansour Mobaseri; Mahdiyeh Moin; Mousa Khani; Amir Hossein Jamshidi; Kambiz Baghalian; Mitra Taghizadeh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

8.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

9.  Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

Authors:  N C Inestrosa; A Alvarez; C A Pérez; R D Moreno; M Vicente; C Linker; O I Casanueva; C Soto; J Garrido
Journal:  Neuron       Date:  1996-04       Impact factor: 17.173

Review 10.  Microglial activation and its implications in the brain diseases.

Authors:  S Thameem Dheen; Charanjit Kaur; Eng-Ang Ling
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  18 in total

Review 1.  Avicenna's pharmacological approach to memory enhancement.

Authors:  Roja Rahimi; Shahrzad Irannejad; Maryam Noroozian
Journal:  Neurol Sci       Date:  2017-02-07       Impact factor: 3.307

Review 2.  Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender.

Authors:  Arezoo Faridzadeh; Yasaman Salimi; Hamidreza Ghasemirad; Meraj Kargar; Ava Rashtchian; Golnaz Mahmoudvand; Mohammad Amin Karimi; Nasibeh Zerangian; Negar Jahani; Anahita Masoudi; Bahare Sadeghian Dastjerdi; Marieh Salavatizadeh; Hamidreza Sadeghsalehi; Niloofar Deravi
Journal:  Front Neurosci       Date:  2022-06-28       Impact factor: 5.152

3.  Effects of Zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus Basalis of Meynert in rat.

Authors:  Zahra Rabiei; Mahmoud Rafieian-Kopaei; Esfandiar Heidarian; Elham Saghaei; Shiva Mokhtari
Journal:  Neurochem Res       Date:  2013-12-31       Impact factor: 3.996

4.  Aqueous Extract of Lavender Angustifolia Inhibits Lymphocytes Proliferation of Hodgkin's Lymphoma Patients.

Authors:  Sona Dalilan; Mostafa Rezaei-Tavirani; Mohammad Nabiuni; Saeed Heidari-Keshel; Mona Zamanian Azodi; Hakimeh Zali
Journal:  Iran J Cancer Prev       Date:  2013

5.  Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease.

Authors:  Hakimeh Zali; Mona Zamanian-Azodi; Mostafa Rezaei Tavirani; Alireza Akbar-Zadeh Baghban
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Lavender and the nervous system.

Authors:  Peir Hossein Koulivand; Maryam Khaleghi Ghadiri; Ali Gorji
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

Review 7.  Modeling Alzheimer's disease with non-transgenic rat models.

Authors:  Laurent Lecanu; Vassilios Papadopoulos
Journal:  Alzheimers Res Ther       Date:  2013-05-01       Impact factor: 6.982

Review 8.  Molecular approaches in obesity studies.

Authors:  Mona Zamanian-Azodi; Reza Vafaee; Taghi Azodi; Roghiyeh Omidi; Samira Gilanchi; Farid Azizi-Jalilian; Reza Khodarahmi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

9.  Proteomics analysis of MKN45 cell line before and after treatment with Lavender aqueous extract.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaie-Tavirani; Saeid Heydari-Kashal; Shiva Kalantari; Sona Dailian; Hakimeh Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012

10.  Effect of essential oil of Rosa Damascena on human colon cancer cell line SW742.

Authors:  Mostafa Rezaie-Tavirani; Setareh Fayazfar; Saeid Heydari-Keshel; Mohamad Bagher Rezaee; Mona Zamanian-Azodi; Majid Rezaei-Tavirani; Reza Khodarahmi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.